v1
Duration of action of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in pediatric kidney transplant recipients.
Identifier:nobleid.org/w1/20260515/D3CD4B16
Type:Conference Paper
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/D3CD4B16)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims